118 related articles for article (PubMed ID: 21251993)
1. Inhaled corticosteroids may have a beneficial effect on bone metabolism in newly diagnosed asthmatic children.
Stelmach I; Olszowiec-Chlebna M; Jerzynska J; Grzelewski T; Stelmach W; Majak P
Pulm Pharmacol Ther; 2011 Aug; 24(4):414-20. PubMed ID: 21251993
[TBL] [Abstract][Full Text] [Related]
2. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma.
Stelmach I; Bobrowska-Korzeniowska M; Majak P; Stelmach W; Kuna P
Pulm Pharmacol Ther; 2005; 18(5):374-80. PubMed ID: 15939317
[TBL] [Abstract][Full Text] [Related]
3. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
4. Effect of inhaled steroid and montelukast on clinical symptoms in children with newly diagnosed asthma: a pilot study.
Olszowiec-Chlebna M; Majak P; Brzozowska A; Bobrowska-Korzeniowska M; Jerzynska J; Stelmach I
Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e687-90. PubMed ID: 20202147
[TBL] [Abstract][Full Text] [Related]
5. Biochemical markers of bone metabolism and calciuria with inhaled budesonide therapy.
Akil I; Yüksel H; Urk V; Var A; Onur E
Pediatr Nephrol; 2004 May; 19(5):511-5. PubMed ID: 15007718
[TBL] [Abstract][Full Text] [Related]
6. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
[TBL] [Abstract][Full Text] [Related]
7. Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group.
Kerstjens HA; Postma DS; van Doormaal JJ; van Zanten AK; Brand PL; Dekhuijzen PN; Koëter GH
Thorax; 1994 Jul; 49(7):652-6. PubMed ID: 8066559
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
Buchvald F; Bisgaard H
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
[TBL] [Abstract][Full Text] [Related]
9. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
[TBL] [Abstract][Full Text] [Related]
10. [Effect of budesonide on bone density and metabolism in asthmatic children].
Paoli de Valeri M; Gómez EM; Valeri E; Salinas R; Bellabarba GA
Salud Publica Mex; 2000; 42(4):309-14. PubMed ID: 11026072
[TBL] [Abstract][Full Text] [Related]
11. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover?
Schou AJ; Heuck C; Wolthers OD
Pediatr Pulmonol; 2003 Nov; 36(5):399-404. PubMed ID: 14520722
[TBL] [Abstract][Full Text] [Related]
12. Influence of inhaled corticosteroids and dietary intake on bone density and metabolism in patients with moderate to severe asthma.
Gagnon L; Boulet LP; Brown J; Desrosiers T
J Am Diet Assoc; 1997 Dec; 97(12):1401-6. PubMed ID: 9404337
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
14. Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma.
Kwda A; Gldc P; Baui B; Kasr K; Us H; S W; Kantha L; Ksh S
BMC Pediatr; 2019 Nov; 19(1):411. PubMed ID: 31684902
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
[TBL] [Abstract][Full Text] [Related]
16. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[TBL] [Abstract][Full Text] [Related]
17. [Inhaled corticosteroid therapy and bone metabolism in asthmatic children].
Galván Fernández C; Oliva Hernández C; Suárez López de Vergara RS; Rodríguez Hernández PJ; Allende Riera A; García-Nieto V; Aguirre-Jaime A
An Pediatr (Barc); 2007 May; 66(5):468-74. PubMed ID: 17517201
[TBL] [Abstract][Full Text] [Related]
18. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
Szefler SJ; Carlsson LG; Uryniak T; Baker JW
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L
Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy.
Kannisto S; Korppi M; Arikoski P; Remes K; Voutilainen R
Pediatr Res; 2002 Aug; 52(2):258-62. PubMed ID: 12149504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
